The U.S. Senate Finance Committee has invited executives from five pharmacy benefit managers to testify on April 3 on the rising costs of prescription medicines, in Congress's latest effort to question industry officials directly over an issue voters consistently cite as a top concern.
from Reuters: Health https://ift.tt/2UxKxbt
via
IFTTT
0 comments: